NCT02582697 2025-06-15
P3BEP
University of Sydney
Phase 3 Recruiting
Clinical Trials
10 trialsNCT02375204 2025-01-13
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT02429687 2023-04-25
MOGCT-01
Shandong University
Phase 3 Recruiting
NCT02429700 2023-04-25
SCST-01
Shandong University
Phase 3 Recruiting
NCT02137096 2019-06-24
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
University of Florida
Phase 3 Terminated
NCT00083915 2017-11-20
DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation
University of Arkansas
Phase 3 Completed
NCT00083551 2015-11-23
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
University of Arkansas
Phase 3 Completed
NCT00433498 2014-12-03
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
University College, London
Phase 3 Completed
NCT00002961 2013-10-16
Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
Children's Hospital of Philadelphia
Phase 3 Terminated
NCT00193596 2013-05-03
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Phase 3 Completed